We sat down with @KulikaC , new General Partner at @Creative_VC & one of the 10 women investors driving the future of Synthetic Biology.
Read her insights into groundbreaking startups she's invested in, offering valuable lessons for women entrepreneurs👉https://t.co/vYUGpzLcqa
Creative Ventures: Where Vision Meets Reality
Our investments focus on scalable technologies that meet realistic, current market demands. Today’s problems can’t be solved by yesterday’s solutions.
Let’s get Creative.
ICYMI: Creative GP James Wang recently contributed an article to Logistics Tech Outlook.
Read his answer to the question, "What is the Potential of AI and Other Technology in Logistics?":
https://t.co/1JqMrYtES3
Our market-first approach and strict investment protocols ensure that we uncover exponential growth opportunities while effectively managing risks, driving change, and revolutionizing industries with our founders.
Check out our portfolio here: https://t.co/fXP9F9G3nP
Ultra-high drug costs can’t and won’t persist in the long-run, simply because society will run out of money to pay for them. As history has proven itself many times over, eventually, the people will rise against a tyrant, perceived or actual.
https://t.co/knSJsQSXRi
At Creative Ventures, we're not just investors – we're deep tech mavens diving deep into cutting-edge solutions that address humanity's most pressing challenges.
Learn more about how we’re breaking boundaries and shaping the future: https://t.co/KQy2zSe4DZ
ICYMI: Creative Ventures GP @AJamesWang is kicking off a new Substack with his "Weighty Thoughts" on compute as a bottleneck to AI.
What are your thoughts?
If you believe the hype, training costs of new AI systems will cost more than US GDP by the 2030s...
That's not going to happen for a number of reasons. I explain why here.
https://t.co/ATyTHpQgIT
Congratulations to the entire @venostent team on two incredibly important achievements!
We are eager to see what comes next and grateful to be a part of your journey toward FDA approval and improving the lives of dialysis patients overall:
https://t.co/H8Sc03yevq
Chip Burr on @PicnicNews pizza robot:
"You can have 10 of the best cooks in the world and they’re each still gonna [make the food] slightly differently, whereas, with this machine, it is 100% the same every time."
Read more here: https://t.co/mr210BUIwV
One thing to be careful of is regulatory capture for AI—inevitably, big tech companies would be happy to put on regulation that makes it harder for competitors to emerge (and entrench their power)
https://t.co/9xXq6LM7rN
Promising direction, pointing more and more to the importance of early diagnosis, which is still relatively difficult to do for neurological diseases given the current standard of care:
https://t.co/ES3sNKTHVt
Early stage and its continued growth throughout the down cycle provides further evidence that early-stage VC is uncorrelated to the market:
https://t.co/xuEC1ck8sr
Platform technology can be both a blessing and a curse for startups. It's important to weigh the potential benefits of expanding the use cases and market opportunities against the risks of diluting limited resources.
https://t.co/BDJ4AayMIz
#startups#platformtechnology
Thank you, @YourProtagonist, for including @champvc1 in your most recent column at @TechCrunch
This is a great round-up of investor insights on what we're looking for in today's day and age
https://t.co/BRj5gssxIL